Etiology/Pathology
Diagnosis
Treatment1
Treatment2
MISC
100

What is the difference between CAP and HAP?

CAP = minimal/no recent healthcare exposure or contact (less than 48h)

HAP = PNA that develops at least 48 hours following hospitalization (VAP = 48h after intubation)

100
What are clinical symptoms associated with CAP?

Cough, Chest Pain, Dyspnea, Fever, Malaise

Atypical: Headache, confusion, diarrhea, CV sx, Skin sx

100

What are the differences associated with the 2007 and 2019 IDSA guidelines for CAP?

Identification of patient populations for sputum and blood culture, HCAP removed as a term (just CAP), treatment recommendations

100

What are risk factors for aspiration PNA?

Elderly, impaired consciousness, lung dx, seizure disorder, stroke, dental issues, dementia, swallowing dysfunction

100

What is the duration of therapy for CAP?

Per IDSA, patient should be afebrile x 48h and receive antibiotic therapy for at least 5 days

200

What are risk factor associated with CAP?

<5yo, >65 yo, Alcoholism; Aspiration; Smoking; Hx of COPD; Exposure to others who are sick; Exposure to animals/farms; HIV; Recent travel; Genetic factors

200

How is severe CAP defined?

IDSA guidelines have major and minor criteria

200

What are options for outpatient treatment for CAP?

Amoxicillin + Macrolide or Doxycycline (most pt)

Augmentin + Macrolide or Doxycycline (major comorbidities)

3rd gen cephalosporins (if allergic to penicillins)

Flouroquinolones (if intolerant to beta-lactams)

200

What group of bacteria are we concerned about for aspiration PNA?

Anaerobes! 

200

What is the duration of therapy for HAP?

ATS recommends shorter course (7 days) for patients with uncomplicated HAP/VAP - inconclusive about longer durations of therapy 

300

What pathogens do we cover for CAP?

Streptococcus pneumonia

Haemophilus Influenzae

Mycoplasma penumonia

Staphylococcus aureus

Chlamydia pneumonia

Legionella pneumophila

Moraxella catarrhalis

300

What is CURB-65?

5 parameters that estimate mortality of CAP to help determine inpatient v outpatient treatment

300

What are options for inpatient treatment of CAP?

Beta lactam + Macrolide 

Flouroquinolone 

Zosyn, cefepime or other anti-psuedomonal if concerned for pseudomonas 

Vancomycin (if concerned for MRSA)

300

What are antimicrobial options for patients with aspiration PNA?

Unasyn (ampicillin/sulbactam)

Flagyl (metronidazole) + amoxicillin

Clindamycin (penicillin allergy)

300
What does pro-calcitonin tell us?

Indicates that a patient has a bacterial infection

400

What pathogens should we cover for HAP?

MRSA/MSSA

Pseudomonas

400

What is the pneumonia severity index?

PSI estimates mortality in patients with CAP using 20 items

400

Which flouroquinolones have good lung penetration

Levofloxacin, Moxifloxacin

400

What are risk factors for MRSA?

Recent use of abc (w/in 90 days)

Prolonged hospitalization

MRSA colonization

Invasive procedures/open wounds

HIV

Nursing homes

400

How do we use pro-calcitonin in an inpatient setting?

De-escalation --> NOT initiation

500

What are risk factors for MDR pathogens?

Recent antibiotic use

ICU admission/Ventilation

Respiratory dx

Prolonged hospital stay

500

What are some differential diagnosis for patients with symptoms of CAP?

COVID-19, Flu, Viral infection, CHF, COPD, Bronchitis, Asthma exacerbation, Aspiration PNA, Drug reaction, Lung dx

500

What is first line treatment for HAP?

Zosyn, Cefepime or Levofloxacin (pseudomonas coverage)
500

What are your treatment options for MRSA?

Vancomycin (1st line)

Linezolid (2nd line)

Doxycycline

Clindamycin

500

What is a DRIP score?

A tool used to guide empiric therapy for CAP in the hospital (based on major and minor risk factors)